These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity. Via CS, Allen RC, Welton RC. J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828 [Abstract] [Full Text] [Related]
3. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095 [Abstract] [Full Text] [Related]
4. Polymorphonuclear leucocyte fluorescence and cryoglobulin phagocytosis in systemic lupus erythematosus. Losito A, Lorusso L. Clin Exp Immunol; 1979 Mar; 35(3):376-9. PubMed ID: 222518 [Abstract] [Full Text] [Related]
6. [Prostaglandins in the pathogenesis of vascular lesions in patients with rheumatic diseases]. Pribytkov IuN, Shilkina NP, Poltyrev AS. Revmatologiia (Mosk); 1990 Mar; (3):7-11. PubMed ID: 1983044 [Abstract] [Full Text] [Related]
7. [Clinical analysis of 70 cases of visceral lupus erythematosus and periarteritis nodosa]. Lawińska-Stankiewicz S. Pol Tyg Lek; 1975 Jun 30; 30(26):1107-10. PubMed ID: 237264 [No Abstract] [Full Text] [Related]
9. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils. Niwa Y, Sakane T, Shingu M, Yokoyama M. J Clin Lab Immunol; 1984 May 30; 14(1):35-43. PubMed ID: 6086929 [Abstract] [Full Text] [Related]
10. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus]. Romanov VA, Borodin AG, Krylov VL. Ter Arkh; 1992 May 30; 64(5):65-9. PubMed ID: 1455381 [Abstract] [Full Text] [Related]
11. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes. Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG. Arthritis Rheum; 1998 Apr 30; 41(4):613-22. PubMed ID: 9550470 [Abstract] [Full Text] [Related]
13. Complement activation and vascular injury in systemic lupus erythematosus. Abramson S, Belmont HM, Hopkins P, Buyon J, Winchester R, Weissmann G. J Rheumatol Suppl; 1987 Jun 30; 14 Suppl 13():43-6. PubMed ID: 2886660 [Abstract] [Full Text] [Related]
14. Phagocytosis, bactericidal capacity, and PGE2 production of monocytes in systemic lupus erythematosus and rheumatoid arthritis. Cruchaud A, Despont JP, Roth A, Dayer JM. Diagn Immunol; 1984 Jun 30; 2(4):203-12. PubMed ID: 6597049 [Abstract] [Full Text] [Related]
16. Serious bacterial cellulitis of the periorbital area in two patients with systemic lupus erythematosus. Derksen RH, Overbeek BP, Poeschmann PH. J Rheumatol; 1988 Jun 30; 15(5):840-4. PubMed ID: 3172097 [Abstract] [Full Text] [Related]
17. [Pleural manifestations in periarteritis nodosa, Wegener's disease and systemic lupus erythematosus]. Lhote F, Cohen P, Chemlal K, Jarrousse B, Guillevin L. Ann Med Interne (Paris); 1992 Jun 30; 143(4):228-32. PubMed ID: 1359823 [No Abstract] [Full Text] [Related]